Laboratory animals: the Renaissance rat, Nature, vol.428, issue.6982, pp.464-466, 2004. ,
Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism, Biochim Biophys Acta, vol.1584, issue.1, pp.9-19, 2002. ,
Harmine is an ATP-competitive inhibitor for dualspecificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A), Arch Biochem Biophys, vol.507, issue.2, pp.212-218, 2011. ,
Green tea polyphenols and their potential role in health and disease, Inflammopharmacology, vol.23, issue.4, pp.151-161, 2015. ,
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits, J Control Release, vol.185, pp.121-129, 2014. ,
Selective Brain-Targeted Antagonism of p38 MAPKalpha Reduces Hippocampal IL1beta Levels and Improves Morris Water Maze Performance in Aged Rats, J Alzheimers Dis, vol.48, issue.1, pp.219-227, 2015. ,
Sex modifies the APOE-related risk of developing Alzheimer disease, Ann Neurol, vol.75, issue.4, pp.563-573, 2014. ,
DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly, J Cell Sci, vol.116, pp.3099-3107, 2003. ,
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice, Brain, vol.140, issue.3, pp.826-842, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01430973
, , 2009.
, Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules, Faseb j, vol.23, issue.4, pp.1146-1152
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease, Lancet, vol.342, issue.8882, p.1309, 1993. ,
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms, J Neurochem, vol.86, issue.3, pp.582-590, 2003. ,
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cereb Cortex, vol.1, issue.1, pp.103-116, 1991. ,
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology, vol.42, issue.3, pp.631-639, 1992. ,
,
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21, Nature, vol.441, issue.7093, pp.595-600, 2006. ,
, , 2016.
, Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression, Mol Neurodegener, vol.11, p.5
, ?APP Processing Drives Gradual Tau Pathology in an AgeDependent Amyloid Rat Model of Alzheimer's Disease, pp.1-18, 2017.
, betaAPP Processing Drives Gradual Tau Pathology in an AgeDependent Amyloid Rat Model of Alzheimer's Disease, pp.1-18, 2017.
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease, Acta Neuropathol, vol.103, issue.1, pp.26-35, 2002. ,
The specificities of protein kinase inhibitors: an update, Biochem J, vol.371, pp.199-204, 2003. ,
Alzheimer's disease, Lancet, vol.377, issue.9770, pp.1019-1031, 2011. ,
Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease, Neuropharmacology, vol.126, pp.128-141, 2017. ,
BACE-2 is overexpressed in Down's syndrome, Exp Neurol, vol.182, issue.2, pp.335-345, 2003. ,
Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus, Neurobiol Aging, vol.34, issue.10, pp.2293-2301, 2013. ,
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology, Mol Psychiatry, vol.35, issue.9, pp.2079-2090, 2014. ,
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests, Mol Psychiatry, vol.14, issue.5, pp.469-486, 2009. ,
Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases, J Biol Chem, vol.273, issue.40, pp.25893-25902, 1998. ,
Cerebral amyloid angiopathy in Down's syndrome, Clin Neuropathol, vol.5, issue.6, pp.257-260, 1986. ,
The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases, J Neurosci, vol.35, issue.6, pp.2817-2829, 2015. ,
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease, Neurology, vol.60, issue.2, pp.246-252, 2003. ,
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease, Trends Neurosci, vol.31, issue.9, pp.454-463, 2008. ,
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron, vol.45, issue.5, pp.675-688, 2005. ,
Dark microglia: A new phenotype predominantly associated with pathological states, Glia, vol.64, issue.5, pp.826-839, 2016. ,
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, issue.4, pp.239-259, 1991. ,
Axonal transport and secretion of fibrillar forms of alpha-synuclein, Abeta42 peptide and HTTExon 1, Acta Neuropathol, vol.131, issue.4, pp.539-548, 2016. ,
Dyrk1 inhibition improves Alzheimer's disease-like pathology, Aging Cell, 2017. ,
An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery, Protein Sci, vol.19, issue.4, pp.763-774, 2010. ,
Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations, Int J Geriatr Psychiatry, vol.29, issue.7, pp.682-693, 2014. ,
Blood-derived amyloid-beta protein induces Alzheimer's disease pathologies, Mol Psychiatry, 2017. ,
A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity, J Biol Chem, vol.285, issue.11, pp.7957-7963, 2010. ,
A high-performance liquid chromatography assay for Dyrk1a, a Down syndromeassociated kinase, Anal Biochem, vol.449, pp.172-178, 2014. ,
Reactive gliosis and the multicellular response to CNS damage and disease, Neuron, vol.81, issue.2, pp.229-248, 2014. ,
,
Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology, Hum Mol Genet, vol.24, issue.21, pp.5965-5976, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01779042
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells, Proc Natl Acad Sci U S A, vol.90, issue.5, pp.2092-2096, 1993. ,
Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains, 2015. ,
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor, Science, vol.259, issue.5094, pp.514-516, 1993. ,
Guide to Research Techniques in Neuroscience, 2015. ,
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice, vol.12, p.36, 2017. ,
Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease, Faseb j, vol.19, issue.14, pp.2040-2041, 2005. ,
Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model, J Neurosci, vol.35, issue.12, pp.4857-4868, 2015. ,
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly, Neurobiol Aging, vol.49, pp.60-68, 2017. ,
Déficit de la mémoire sémantique dans la démence de type Alzheimer, 2005. ,
Localisation of a human homologue of the Drosophila mnb and rat Dyrk genes to chromosome 21q22.2, Hum Genet, vol.99, issue.2, pp.262-265, 1997. ,
A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse), Mol Neurobiol, vol.47, issue.2, pp.711-725, 2013. ,
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II), Amino Acids, vol.24, issue.1-2, pp.119-125, 2003. ,
Amyloidbeta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons, Mol Psychiatry, vol.14, issue.2, pp.206-222, 2009. ,
,
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum, Ann Neurol, vol.80, issue.2, pp.247-258, 2016. ,
Continuum of overlapping clones spanning the entire human chromosome 21q, Nature, vol.359, issue.6394, pp.380-387, 1992. ,
Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production, Nature, vol.360, issue.6405, pp.672-674, 1992. ,
Transmission and spreading of tauopathy in transgenic mouse brain, Nat Cell Biol, vol.11, issue.7, pp.909-913, 2009. ,
Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons, Brain Res, vol.1142, pp.223-236, 2007. ,
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease, Brain, vol.137, pp.2834-2846, 2014. ,
Dementia and mortality in persons with Down's syndrome, J Intellect Disabil Res, vol.50, pp.768-777, 2006. ,
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-923, 1993. ,
,
A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro, J Neurochem, vol.133, issue.3, pp.440-451, 2015. ,
Alzheimer's disease drug development pipeline: 2017, Alzheimers Dement (N Y), vol.3, issue.3, pp.367-384, 2017. ,
Brain oligomeric beta-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice, J Neuropathol Exp Neurol, vol.70, issue.5, pp.360-376, 2011. ,
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice, J Biol Chem, vol.280, issue.25, pp.23802-23814, 2005. ,
Caspase activation precedes and leads to tangles, Nature, vol.464, issue.7292, pp.1201-1204, 2010. ,
Propagation of tau pathology in a model of early Alzheimer's disease, Neuron, vol.73, issue.4, pp.685-697, 2012. ,
,
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial, Lancet Neurol, vol.15, issue.8, pp.801-810, 2016. ,
Interaction between hypertension, apoE, and cerebral white matter lesions, Stroke, vol.35, issue.5, pp.1057-1060, 2004. ,
RAGE mediates amyloidbeta peptide transport across the blood-brain barrier and accumulation in brain, Nat Med, vol.9, issue.7, pp.907-913, 2003. ,
Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing, J Med Chem, vol.54, issue.12, pp.4172-4186, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00870007
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity, Ann Neurol, vol.27, issue.5, pp.457-464, 1990. ,
Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study, J Alzheimers Dis, vol.33, issue.1, pp.205-215, 2013. ,
Molecular mapping of twenty-four features of Down syndrome on chromosome 21, Eur J Hum Genet, vol.1, issue.2, pp.114-124, 1993. ,
, Tau reduction in the presence of amyloid-beta prevents tau pathology and neuronal death in vivo, 2018.
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders, Trends Pharmacol Sci, vol.29, issue.8, pp.402-412, 2008. ,
HSP induction mediates selective clearance of tau phosphorylated at prolinedirected Ser/Thr sites but not KXGS (MARK) sites, Faseb j, vol.20, issue.6, pp.753-755, 2006. ,
Differential regulation of dynein and kinesin motor proteins by tau, Science, vol.319, issue.5866, pp.1086-1089, 2008. ,
Modeling Alzheimer's disease in transgenic rats, Mol Neurodegener, vol.8, p.37, 2013. ,
Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults, Am J Psychiatry, p.201717040442, 2018. ,
A phase 3 trial of semagacestat for treatment of Alzheimer's disease, N Engl J Med, vol.369, issue.4, pp.341-350, 2013. ,
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome, Neurosci Lett, vol.413, issue.1, pp.77-81, 2007. ,
Estrogen and neuroprotection: from clinical observations to molecular mechanisms, Dialogues Clin Neurosci, vol.4, issue.2, pp.149-161, 2002. ,
Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study, Lancet Neurol, 2018. ,
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, vol.6, issue.8, pp.734-746, 2007. ,
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, vol.13, issue.6, pp.614-629, 2014. ,
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimers Dement, vol.12, issue.3, pp.292-323, 2016. ,
Alzheimer disease models and human neuropathology: similarities and differences, Acta Neuropathol, vol.115, issue.1, pp.5-38, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00320572
Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex, J Alzheimers Dis, vol.6, issue.3, pp.209-219, 2004. ,
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study, Neurology, vol.68, issue.7, pp.501-508, 2007. ,
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept, Alzheimers Dement, vol.13, issue.4, pp.454-467, 2017. ,
Neuropathologic basis of age-associated brain atrophy, JAMA Neurol, vol.70, issue.5, pp.616-622, 2013. ,
Ageing and the brain, J Pathol, vol.211, issue.2, pp.181-187, 2007. ,
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, Jama, vol.278, issue.16, pp.1349-1356, 1997. ,
Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies, Mol Med, vol.17, issue.7-8, pp.676-685, 2011. ,
Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease, Front Cell Neurosci, vol.9, p.191, 2015. ,
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models, Neurobiol Dis, vol.20, issue.2, pp.392-400, 2005. ,
The biology of aging in model organisms, Alzheimer Dis Assoc Disord, vol.17, pp.39-41, 2003. ,
The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms, Neurobiol Aging, vol.20, issue.4, pp.407-428, 1999. ,
Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules, Biochemistry, vol.48, issue.42, pp.10047-10055, 2009. ,
,
A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition, Neurobiol Aging, vol.30, issue.7, pp.1078-1090, 2009. ,
Viral gene transfer of APPsalpha rescues synaptic failure in an Alzheimer's disease mouse model, Acta Neuropathol, 2015. ,
A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation, Biochem Biophys Res Commun, vol.358, issue.3, pp.777-782, 2007. ,
Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-198, 1975. ,
Alzheimer's disease-like pathology induced by amyloid-beta oligomers in nonhuman primates, vol.34, pp.13629-13643, 2014. ,
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice, Glia, vol.56, issue.13, pp.1438-1447, 2008. ,
,
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease, Neurobiol Dis, vol.24, issue.3, pp.516-524, 2006. ,
Systemic catabolism of Alzheimer's Abeta40 and Abeta42, J Biol Chem, vol.279, issue.44, pp.45897-45908, 2004. ,
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology, vol.60, issue.9, pp.1495-1500, 2003. ,
Early intervention in the 3xTg-AD mice with an amyloid beta-antibody fragment ameliorates first hallmarks of Alzheimer disease, MAbs, vol.5, issue.5, pp.665-677, 2013. ,
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun, vol.120, issue.3, pp.885-890, 1984. ,
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, vol.349, issue.6311, pp.704-706, 1991. ,
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation, Febs j, vol.276, issue.21, pp.6324-6337, 2009. ,
Les médicaments contre Alzheimer ne seront plus remboursés à compter du 1er août, 2018. ,
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease, Science, vol.235, issue.4791, pp.877-880, 1987. ,
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann Neurol, vol.41, issue.1, pp.17-24, 1997. ,
Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau, J Cell Biol, vol.124, issue.5, pp.769-782, 1994. ,
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils, Science, vol.293, issue.5534, pp.1491-1495, 2001. ,
Animal models of Alzheimer's disease and frontotemporal dementia, Nat Rev Neurosci, vol.9, issue.7, pp.532-544, 2008. ,
Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform, Embo j, vol.14, issue.7, pp.1304-1313, 1995. ,
Intraneuronal Abeta42 accumulation in human brain, Am J Pathol, vol.156, issue.1, pp.15-20, 2000. ,
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau, J Biol Chem, vol.267, issue.1, pp.564-569, 1992. ,
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc Natl Acad Sci U S A, vol.83, issue.13, pp.4913-4917, 1986. ,
DYRK1A: a master regulatory protein controlling brain growth, Neurobiol Dis, vol.46, issue.1, pp.190-203, 2012. ,
Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A, PLoS One, vol.4, issue.2, p.4606, 2009. ,
,
, TREM2 variants in Alzheimer's disease, vol.368, pp.117-127, 2013.
Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome, Genomics, vol.57, issue.3, pp.407-418, 1999. ,
A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region, Hum Mol Genet, vol.5, issue.9, pp.1305-1310, 1996. ,
Intraneuronal abetaamyloid precedes development of amyloid plaques in Down syndrome, Arch Pathol Lab Med, vol.125, issue.4, pp.489-492, 2001. ,
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat Rev Mol Cell Biol, vol.8, issue.2, pp.101-112, 2007. ,
,
Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging, Brain, vol.139, pp.1252-1264, 2016. ,
The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications, J Neural Transm Suppl, issue.67, pp.129-137, 2003. ,
The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development, Eur J Neurosci, vol.27, issue.5, pp.1061-1074, 2008. ,
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification, Faseb j, vol.9, issue.8, pp.576-596, 1995. ,
Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members, Methods Enzymol, vol.200, pp.38-62, 1991. ,
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains, Science, vol.241, issue.4861, pp.42-52, 1988. ,
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders, Nat Rev Neurosci, vol.11, issue.10, pp.682-696, 2010. ,
Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends Pharmacol Sci, vol.12, issue.10, pp.383-388, 1991. ,
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, vol.297, issue.5580, pp.353-356, 2002. ,
Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, pp.184-185, 1992. ,
,
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides, Nat Med, vol.3, issue.9, pp.1016-1020, 1997. ,
14-3-3zeta is an effector of tau protein phosphorylation, J Biol Chem, vol.275, issue.33, pp.25247-25254, 2000. ,
Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment, Acta Neuropathol, vol.133, issue.5, pp.717-730, 2017. ,
,
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology, Acta Neuropathol, 2017. ,
Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention, J Alzheimers Dis, vol.11, issue.1, pp.61-76, 2007. ,
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology, Curr Alzheimer Res, vol.13, issue.1, pp.18-29, 2016. ,
The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus, J Recept Signal Transduct Res, vol.19, issue.1-4, pp.75-120, 1999. ,
Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City Study, Dement Geriatr Cogn Disord, vol.26, issue.5, pp.407-415, 2008. ,
,
Neuroinflammation in Alzheimer's disease, Lancet Neurol, vol.14, issue.4, pp.388-405, 2015. ,
Innate immune activation in neurodegenerative disease, Nat Rev Immunol, vol.14, issue.7, pp.463-477, 2014. ,
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice, J Neuroinflammation, vol.2, p.22, 2005. ,
Immune attack: the role of inflammation in Alzheimer disease, Nat Rev Neurosci, vol.16, issue.6, pp.358-372, 2015. ,
The case for rejecting the amyloid cascade hypothesis, Nat Neurosci, vol.18, issue.6, pp.794-799, 2015. ,
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice, J Neurosci, vol.28, issue.33, pp.8354-8360, 2008. ,
Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology, Ann N Y Acad Sci, vol.695, pp.224-227, 1993. ,
Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration, Neuron, vol.35, issue.3, pp.433-446, 2002. ,
Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A, Biochem J, vol.359, pp.497-505, 2001. ,
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, Lancet, vol.372, issue.9634, pp.216-223, 2008. ,
Systemic inflammation and disease progression in Alzheimer disease, Neurology, vol.73, issue.10, pp.768-774, 2009. ,
Apolipoprotein E influences amyloid-beta clearance from the murine periphery, J Alzheimers Dis, vol.5, issue.1, pp.1-8, 2003. ,
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog, Embo j, vol.16, issue.18, pp.5572-5581, 1997. ,
Receptor tyrosine kinases: mechanisms of activation and signaling, Curr Opin Cell Biol, vol.19, issue.2, pp.117-123, 2007. ,
The conformational plasticity of protein kinases, Cell, vol.109, issue.3, pp.275-282, 2002. ,
Alzheimer's disease: cellspecific pathology isolates the hippocampal formation, Science, vol.225, issue.4667, pp.1168-1170, 1984. ,
Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Abeta1-40/Abeta1-42, Amyloid, vol.19, issue.4, pp.186-190, 2012. ,
Tau pathology in Alzheimer disease and other tauopathies, Biochim Biophys Acta, vol.1739, issue.2-3, pp.198-210, 2005. ,
Defective brain microtubule assembly in Alzheimer's disease, Lancet, vol.2, issue.8504, pp.421-426, 1986. ,
,
,
Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer's mice, Science, vol.354, issue.6314, pp.904-908, 2016. ,
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia, Proc Natl Acad Sci U S A, vol.105, issue.41, pp.15997-16002, 2008. ,
,
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models, Cell, vol.142, issue.3, pp.387-397, 2010. ,
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-216, 2013. ,
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet Neurol, vol.9, issue.1, pp.119-128, 2010. ,
Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study, Lancet Neurol, vol.15, issue.1, pp.56-64, 2016. ,
Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease, Transl Psychiatry, vol.7, issue.6, p.1154, 2017. ,
Plasma DYRK1A as a novel risk factor for Alzheimer's disease, Transl Psychiatry, vol.4, p.425, 2014. ,
DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression, EMBO Rep, vol.15, issue.6, pp.686-694, 2014. ,
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum Mol Genet, vol.13, issue.2, pp.159-170, 2004. ,
Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice, J Biol Chem, vol.282, issue.31, pp.22707-22720, 2007. ,
,
Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE, J Biol Chem, vol.290, issue.24, pp.15219-15237, 2015. ,
Variant of TREM2 associated with the risk of Alzheimer's disease, N Engl J Med, vol.368, issue.2, pp.107-116, 2013. ,
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature, vol.325, issue.6106, pp.733-736, 1987. ,
Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII, J Biol Chem, vol.271, issue.7, pp.3488-3495, 1996. ,
Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-beta peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors, J Alzheimers Dis, vol.32, issue.1, pp.183-196, 2012. ,
Physiology of microglia, Physiol Rev, vol.91, issue.2, pp.461-553, 2011. ,
,
, The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells, 2015.
Paired helical filaments in electron microscopy of Alzheimer's disease, Nature, vol.197, pp.192-193, 1963. ,
Selective inhibition of the kinase DYRK1A by targeting its folding process, Nat Commun, vol.7, p.11391, 2016. ,
Inhibition of monoamine oxidase A by beta-carboline derivatives, Arch Biochem Biophys, vol.337, issue.1, pp.137-142, 1997. ,
The reduction of NADH ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease, Life Sci, vol.68, issue.24, pp.2741-2750, 2001. ,
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease, Hum Mol Genet, vol.16, issue.1, pp.15-23, 2007. ,
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, Neurobiol Dis, vol.33, issue.2, pp.229-235, 2009. ,
Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions, Curr Pharm Des, vol.18, issue.8, pp.1131-1147, 2012. ,
Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer's disease, J Cell Mol Med, vol.14, issue.6b, pp.1816-1823, 2010. ,
Alzheimer's second patient: Johann F. and his family, Ann Neurol, vol.52, issue.4, pp.520-523, 2002. ,
Calpain is a mediator of preservationreperfusion injury in rat liver transplantation, Proc Natl Acad Sci U S A, vol.94, issue.17, pp.9354-9359, 1997. ,
Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up, Int J Geriatr Psychiatry, vol.31, issue.3, pp.273-283, 2016. ,
The non-amyloidogenic pathway: structure and function of alphasecretases, Subcell Biochem, vol.38, pp.105-127, 2005. ,
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy, Nature, vol.523, issue.7561, pp.431-436, 2015. ,
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease, Alzheimers Res Ther, vol.6, issue.4, p.45, 2014. ,
Soluble forms of tau are toxic in Alzheimer's disease, Transl Neurosci, vol.3, issue.3, pp.223-233, 2012. ,
Defining the conserved internal architecture of a protein kinase, Biochim Biophys Acta, vol.1804, issue.3, pp.440-444, 2010. ,
Quelle place pour les biomarqueurs dans le diagnostic de la maladie d'Alzheimer et des maladies apparentées ?, Psychol NeuroPsychiatr Vieil, vol.8, issue.1, pp.25-31, 2010. ,
DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model, EMBO Rep, vol.16, issue.11, pp.1548-1562, 2015. ,
Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain, vol.4, p.34, 2016. ,
Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes, Neurobiol Dis, vol.14, issue.1, pp.89-97, 2003. ,
Intracellular amyloid-beta in Alzheimer's disease, Nat Rev Neurosci, vol.8, issue.7, pp.499-509, 2007. ,
Ushering in the study and treatment of preclinical Alzheimer disease, Nat Rev Neurol, vol.9, issue.7, pp.371-381, 2013. ,
The grey mouse lemur: a non-human primate model for ageing studies, Ageing Res Rev, vol.11, issue.1, pp.150-162, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00650159
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice, Mol Neurodegener, vol.6, p.39, 2011. ,
, , 1997.
, Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia, J Cereb Blood Flow Metab, vol.17, issue.7, pp.753-758
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy, vol.21, pp.97-107, 2016. ,
Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1, J Neurosci, vol.27, issue.26, pp.7011-7020, 2007. ,
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, vol.111, pp.3825-3830, 2014. ,
An update of animal models of Alzheimer disease with a reevaluation of plaque depositions, Exp Neurobiol, vol.22, issue.2, pp.84-95, 2013. ,
APP processing is regulated by cytoplasmic phosphorylation, J Cell Biol, vol.163, issue.1, pp.83-95, 2003. ,
Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, vol.405, issue.6784, pp.360-364, 2000. ,
The risk of dementia among persons with diabetes mellitus: a population-based cohort study, Ann N Y Acad Sci, vol.826, pp.422-427, 1997. ,
A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment, J Alzheimers Dis, vol.20, issue.1, pp.113-126, 2010. ,
Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, vol.269, issue.5226, pp.973-977, 1995. ,
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, vol.248, issue.4959, pp.1124-1126, 1990. ,
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science, vol.293, issue.5534, pp.1487-1491, 2001. ,
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat Genet, vol.25, issue.4, pp.402-405, 2000. ,
Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation, vol.36, pp.3120-3138, 2017. ,
Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors, J Neurosci, vol.31, issue.18, pp.6627-6638, 2011. ,
Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration, Embo j, vol.30, issue.23, pp.4825-4837, 2011. ,
Neurotoxic reactive astrocytes are induced by activated microglia, Nature, vol.541, issue.7638, pp.481-487, 2017. ,
Dual-specificity protein kinases: will any hydroxyl do?, Trends Biochem Sci, vol.17, issue.3, pp.114-119, 1992. ,
Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer's disease, Neuron, vol.84, issue.1, pp.63-77, 2014. ,
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome, Faseb j, vol.22, issue.9, pp.3224-3233, 2008. ,
Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs, Cell, vol.121, issue.6, pp.925-936, 2005. ,
Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-beta, J Alzheimers Dis, vol.6, issue.4, pp.443-429, 2004. ,
Good fats prevent dendritic damage in mouse model of AD, Lancet Neurol, vol.3, issue.11, p.636, 2004. ,
Cerebrovascular disease in ageing and Alzheimer's disease, Acta Neuropathol, vol.131, issue.5, pp.645-658, 2016. ,
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort, Am J Epidemiol, vol.154, issue.7, pp.635-641, 2001. ,
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am J Pathol, vol.155, issue.3, pp.853-862, 1999. ,
Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease, J Alzheimers Dis, vol.12, issue.4, pp.365-375, 2007. ,
Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques, Neurology, vol.46, issue.2, pp.425-429, 1996. ,
Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions, Vascul Pharmacol, vol.38, issue.6, pp.303-313, 2002. ,
Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein, Proc Natl Acad Sci U S A, vol.96, issue.8, pp.4656-4661, 1999. ,
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis, J Neurosci, vol.29, issue.13, pp.4252-4262, 2009. ,
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome, J Neurol Sci, vol.89, issue.2-3, pp.169-179, 1989. ,
The protein kinase complement of the human genome, Science, vol.298, issue.5600, pp.1912-1934, 2002. ,
,
Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain, Brain, vol.138, pp.1738-1755, 2015. ,
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology, J Intellect Disabil Res, vol.51, pp.463-477, 2007. ,
Health inequalities among British civil servants: the Whitehall II study, Lancet, vol.337, pp.1387-1393, 1991. ,
,
Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system, Brain Res, vol.964, issue.2, pp.250-263, 2003. ,
Post-translational modifications of tau protein: implications for Alzheimer's disease, Neurochem Int, vol.58, issue.4, pp.458-471, 2011. ,
Mechanisms of synaptic dysfunction in Alzheimer's disease, Histol Histopathol, vol.10, issue.2, pp.509-519, 1995. ,
Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, J Neuropathol Exp Neurol, vol.60, issue.4, pp.357-368, 2001. ,
Neuronal origin of cerebral amyloidogenic proteins: their role in Alzheimer's disease and unconventional virus diseases of the nervous system, Ciba Found Symp, vol.126, pp.49-64, 1987. ,
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein, Neuron, vol.10, issue.2, pp.243-254, 1993. ,
Amnesia induced in mice by centrally administered betaamyloid peptides involves cholinergic dysfunction, Brain Res, vol.706, issue.2, pp.181-193, 1996. ,
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases, Nat Rev Drug Discov, vol.6, issue.6, pp.464-479, 2007. ,
Review of emotion recognition in mild cognitive impairment, Dement Geriatr Cogn Disord, vol.32, issue.4, pp.257-266, 2011. ,
Stop Alzheimer's before it starts, Nature, vol.547, issue.7662, pp.153-155, 2017. ,
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome, Hum Mol Genet, vol.25, issue.22, pp.4856-4869, 2016. ,
Targeting microglia for the treatment of Alzheimer's disease, Expert Opin Ther Targets, vol.19, issue.4, pp.497-506, 2015. ,
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann Neurol, vol.46, issue.6, pp.860-866, 1999. ,
Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice, Am J Pathol, vol.181, issue.2, pp.616-625, 2012. ,
, , 2016.
, Multimodality Review of Amyloid-related Diseases of the Central Nervous System, Radiographics, vol.36, issue.4, pp.1147-1163
The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections, Eur Arch Psychiatry Clin Neurosci, vol.248, issue.3, pp.111-122, 1998. ,
,
Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood, Neurobiol Aging, vol.23, issue.3, pp.405-412, 2002. ,
GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model, J Alzheimers Dis, vol.26, issue.3, pp.447-455, 2011. ,
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo, ACS Chem Neurosci, vol.3, issue.11, pp.963-971, 2012. ,
Type 2 Diabetes Mellitus and Alzheimer's Disease: from physiopathology to treatment implications, Diabetes Metab Res Rev, 2013. ,
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice, vol.18, pp.1183-1189, 2015. ,
The many faces of tau, Neuron, vol.70, issue.3, pp.410-426, 2011. ,
Spatial localization does not require the presence of local cues, Learning and Motivation, vol.12, issue.2, pp.239-260, 1981. ,
,
What is the evidence that tau pathology spreads through prion-like propagation?, Acta Neuropathol Commun, vol.5, issue.1, p.99, 2017. ,
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications, Expert Rev Neurother, vol.8, issue.11, pp.1703-1718, 2008. ,
Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization, J Am Chem Soc, vol.131, issue.18, pp.6316-6317, 2009. ,
Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J Neurochem, vol.63, issue.6, pp.2179-2184, 1994. ,
Amyloid-beta-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease, Anal Chem, vol.88, issue.5, pp.2755-2762, 2016. ,
Amyloid blood biomarker detects Alzheimer's disease, p.10, 2018. ,
,
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Abeta peptide administration in mice, Eur Neuropsychopharmacol, 2015. ,
High performance plasma amyloid-beta biomarkers for Alzheimer's disease, Nature, vol.554, issue.7691, pp.249-254, 2018. ,
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature, Expert Opin Ther Pat, vol.27, issue.11, pp.1183-1199, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02046302
,
Alpha-and beta-secretase activity as a function of age and betaamyloid in Down syndrome and normal brain, Neurobiol Aging, vol.28, issue.10, pp.1493-1506, 2007. ,
,
Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models, J Neurosci, vol.25, issue.18, pp.4649-4658, 2005. ,
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome, Neuron, vol.43, issue.3, pp.321-332, 2004. ,
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease, Proc Natl Acad Sci U S A, vol.102, issue.8, pp.3046-3051, 2005. ,
,
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron, vol.39, issue.3, pp.409-421, 2003. ,
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology, J Biol Chem, vol.281, issue.3, pp.1599-1604, 2006. ,
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A, Nat Commun, vol.1, p.86, 2010. ,
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET, Brain, vol.137, pp.1762-1771, 2014. ,
High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development, Genomics, vol.62, issue.2, pp.165-171, 1999. ,
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies, Aging Dis, vol.7, issue.2, pp.201-214, 2016. ,
Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome, Am J Hum Genet, vol.83, issue.4, pp.479-488, 2008. ,
Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease, Mol Neurodegener, vol.6, p.45, 2011. ,
Function and regulation of Dyrk1A: towards understanding Down syndrome, Cell Mol Life Sci, vol.66, issue.20, pp.3235-3240, 2009. ,
Extrasynaptic NMDA receptor involvement in central nervous system disorders, Neuron, vol.82, issue.2, pp.279-293, 2014. ,
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis, Am J Pathol, vol.169, issue.3, pp.1048-1063, 2006. ,
Kinome signaling through regulated protein-protein interactions in normal and cancer cells, Curr Opin Cell Biol, vol.21, issue.2, pp.147-153, 2009. ,
Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia, Nat Med, vol.20, issue.5, pp.542-547, 2014. ,
Neuropathology of Alzheimer's disease, Mt Sinai J Med, vol.77, issue.1, pp.32-42, 2010. ,
La maladie d'Alzheimer et la prise en charge infirmière, 2007. ,
Alzheimer's mouse model raises treatment queries, Lancet Neurol, vol.5, issue.1, p.28, 2006. ,
Surgical menopause and cognitive decline, Climacteric, vol.17, issue.5, pp.580-582, 2014. ,
Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease, Neurobiol Aging, vol.26, issue.3, pp.355-361, 2005. ,
Amyloid-beta and tau complexity -towards improved biomarkers and targeted therapies, Nat Rev Neurol, vol.14, issue.1, pp.22-39, 2018. ,
Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons, vol.6, p.10, 2018. ,
Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model, Acta Neuropathol, vol.127, issue.2, pp.257-270, 2014. ,
The GK rat: a prototype for the study of non-overweight type 2 diabetes, Methods Mol Biol, vol.933, pp.125-159, 2012. ,
Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats, Aging Cell, vol.9, issue.5, pp.722-735, 2010. ,
Microglia actions in Alzheimer's disease, Acta Neuropathol, vol.126, issue.4, pp.461-477, 2013. ,
The Alzheimer disease market, Nat Rev Drug Discov, vol.14, issue.10, pp.675-676, 2015. ,
Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia, Neurology, vol.85, issue.10, pp.898-904, 2015. ,
PEST sequences and regulation by proteolysis, Trends Biochem Sci, vol.21, issue.7, pp.267-271, 1996. ,
Tau phosphorylation at serine 396 residue is required for hippocampal LTD, vol.35, pp.4804-4812, 2015. ,
,
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model, Science, vol.316, issue.5825, pp.750-754, 2007. ,
,
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease, Nat Genet, vol.39, issue.2, pp.168-177, 2007. ,
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis, Science, vol.234, issue.4774, pp.364-368, 1986. ,
Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition, Neurobiol Aging, vol.36, issue.1, pp.149-156, 2015. ,
URL : https://hal.archives-ouvertes.fr/mnhn-02291873
Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs, Faseb j, vol.25, issue.11, pp.3896-3905, 2011. ,
Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats, Mol Med, vol.10, issue.1-6, pp.36-44, 2004. ,
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease, J Neurochem, vol.104, issue.5, pp.1333-1344, 2008. ,
,
DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease, J Biol Chem, vol.282, issue.48, pp.34850-34857, 2007. ,
,
Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease, J Neurochem, vol.115, issue.3, pp.574-584, 2010. ,
The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a Cost, Front Neurosci, vol.10, p.3, 2016. ,
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics, Annu Rev Neurosci, vol.39, pp.57-79, 2016. ,
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease, N Engl J Med, vol.370, issue.15, p.1460, 2014. ,
Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease, J Neuropathol Exp Neurol, vol.57, issue.12, pp.1146-1153, 1998. ,
Alzheimer's disease, Lancet, vol.388, pp.505-517, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01723790
, , 2006.
, Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am J Pathol, vol.169, issue.2, pp.599-616
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc Natl Acad Sci U S A, vol.90, issue.20, pp.9649-9653, 1993. ,
Alzheimer's disease. In the beginning, Nature, vol.354, issue.6353, pp.432-433, 1991. ,
Alzheimer's disease is a synaptic failure, Science, vol.298, issue.5594, pp.789-791, 2002. ,
The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol Med, vol.8, issue.6, pp.595-608, 2016. ,
In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease, J Neuropathol Exp Neurol, vol.58, issue.9, pp.1020-1026, 1999. ,
A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo, Neurobiol Dis, vol.35, issue.3, pp.359-367, 2009. ,
Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment, Neuroimmunomodulation, vol.21, issue.2-3, pp.79-87, 2014. ,
Neuropathological alterations in Alzheimer disease, Cold Spring Harb Perspect Med, vol.1, issue.1, p.6189, 2011. ,
,
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, vol.375, issue.6534, pp.754-760, 1995. ,
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy, Nature, vol.549, issue.7673, pp.523-527, 2017. ,
Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau, Acta Neuropathol, vol.113, issue.6, pp.627-636, 2007. ,
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease, Am J Geriatr Psychiatry, vol.10, issue.1, pp.24-35, 2002. ,
The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain, J Biol Chem, vol.274, issue.43, pp.30874-30881, 1999. ,
Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease, Neuron, vol.49, issue.4, pp.489-502, 2006. ,
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies, Biomolecules, vol.6, issue.1, p.6, 2016. ,
Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study, JAMA Psychiatry, vol.74, issue.7, pp.712-718, 2017. ,
Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis, Neuron, vol.60, issue.4, pp.534-542, 2008. ,
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?, ACS Chem Neurosci, vol.3, issue.11, pp.857-872, 2012. ,
Cosmid assembly and anchoring to human chromosome 21, Genomics, vol.25, issue.1, pp.73-84, 1995. ,
Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators, Neuroscientist, vol.20, issue.2, pp.160-172, 2014. ,
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia, J Neuroinflammation, vol.6, p.1, 2009. ,
The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers, Biochem Biophys Res Commun, vol.231, issue.3, pp.640-644, 1997. ,
,
Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region, Genomics, vol.38, issue.3, pp.331-339, 1996. ,
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models, Front Behav Neurosci, vol.9, p.267, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01263753
, , 2014.
, Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage, Neurobiol Dis, vol.69, pp.65-75
, , 2018.
, Alzheimer's disease drug development strategy by targeting its silent phase, NEURAL REGENERATION RESEARCH
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on AgingAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, issue.3, pp.280-292, 2011. ,
Tau pathology and neurodegeneration, Lancet Neurol, vol.12, issue.6, pp.609-622, 2013. ,
Are tangles as toxic as they look?, J Mol Neurosci, vol.45, issue.3, pp.438-444, 2011. ,
Tau pathophysiology in neurodegeneration: a tangled issue, Trends Neurosci, vol.32, issue.3, pp.150-159, 2009. ,
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy, Am J Pathol, vol.168, issue.5, pp.1598-1607, 2006. ,
,
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice, Neurobiol Dis, vol.74, pp.204-218, 2015. ,
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci U S A, vol.90, issue.5, pp.1977-1981, 1993. ,
Neural plasticity and behavior -sixty years of conceptual advances, J Neurochem, vol.139, pp.179-199, 2016. ,
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B, J Med Chem, vol.55, issue.21, pp.9312-9330, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00870472
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes, Proc Natl Acad Sci U S A, vol.107, issue.15, pp.7036-7041, 2010. ,
Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, Proc Natl Acad Sci U S A, vol.110, issue.27, pp.2518-2527, 2013. ,
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, J Neurosci, vol.22, issue.1, pp.133-141, 2002. ,
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases, Mol Neurobiol, vol.53, issue.2, pp.1181-1194, 2016. ,
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell, vol.120, issue.4, pp.545-555, 2005. ,
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, vol.235, issue.4791, pp.880-884, 1987. ,
Intrathecal inflammation precedes development of Alzheimer's disease, J Neurol Neurosurg Psychiatry, vol.74, issue.9, pp.1200-1205, 2003. ,
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome, Nat Med, vol.2, issue.1, pp.93-95, 1996. ,
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, vol.30, issue.4, pp.572-580, 1991. ,
Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, issue.12, pp.1791-1800, 2002. ,
A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo, J Neurosci, vol.30, issue.14, pp.4845-4856, 2010. ,
Genome-wide association studies in Alzheimer's disease: a review, Curr Neurol Neurosci Rep, vol.13, issue.10, p.381, 2013. ,
The role of microglia in the healthy brain, J Neurosci, vol.31, issue.45, pp.16064-16069, 2011. ,
,
Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease, J Clin Invest, vol.118, issue.8, pp.2796-2807, 2008. ,
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach, Curr Alzheimer Res, vol.9, issue.4, pp.397-405, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00664452
Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data, Ann Epidemiol, vol.16, issue.6, pp.477-484, 2006. ,
Mechanisms of specificity in protein phosphorylation, Nat Rev Mol Cell Biol, vol.8, issue.7, pp.530-541, 2007. ,
Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment, Dement Geriatr Cogn Disord, vol.31, issue.4, pp.276-283, 2011. ,
,
DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort, BMC Med Genet, vol.10, p.129, 2009. ,
Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study, Lancet Neurol, vol.12, issue.4, pp.357-367, 2013. ,
, p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice, vol.575, pp.96-100, 2014.
Mechanism of dual specificity kinase activity of DYRK1A, Febs j, vol.280, issue.18, pp.4495-4511, 2013. ,
, , 2010.
, /STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease, J Neurosci, vol.30, pp.6873-6881
betaAmyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology, J Biol Chem, vol.275, issue.8, pp.5626-5632, 2000. ,
The release and trans-synaptic transmission of Tau via exosomes, Mol Neurodegener, vol.12, issue.1, p.5, 2017. ,
TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model, Cell, vol.160, issue.6, pp.1061-1071, 2015. ,
Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-beta, Neurosci Bull, vol.29, issue.6, pp.752-760, 2013. ,
The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome, Acta Neuropathol, vol.116, issue.4, pp.391-407, 2008. ,
The role of DYRK1A in neurodegenerative diseases, Febs j, vol.278, issue.2, pp.236-245, 2011. ,
Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome, J Neuropathol Exp Neurol, vol.70, issue.1, pp.36-50, 2011. ,
Cell type-and brain structurespecific patterns of distribution of minibrain kinase in human brain, Brain Res, vol.1010, issue.1-2, pp.69-80, 2004. ,
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice, Neurobiol Aging, vol.22, issue.1, pp.49-61, 2001. ,
A protein factor essential for microtubule assembly, Proc Natl Acad Sci U S A, vol.72, issue.5, pp.1858-1862, 1975. ,
Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy, Acta Neuropathol, vol.118, issue.1, pp.87-102, 2009. ,
Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain, Neurol Res, vol.25, issue.6, pp.611-616, 2003. ,
)): The teachings of a senseless polemic, Presse Med, vol.46, issue.10, pp.887-889, 2017. ,
Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study, Lancet Neurol, vol.17, issue.2, pp.123-132, 2018. ,
Unusual function of the activation loop in the protein kinase DYRK1A, Biochem Biophys Res Commun, vol.302, issue.2, pp.403-408, 2003. ,
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low-and high-CSF A beta 40 load, J Neurochem, vol.101, issue.4, pp.1053-1059, 2007. ,
Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome, Ann N Y Acad Sci, vol.477, pp.247-260, 1986. ,
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome, Ann Neurol, vol.17, issue.3, pp.278-282, 1985. ,
Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles, Science, vol.293, issue.5530, pp.711-714, 2001. ,
Molecule-pharmacophore superpositioning and pattern matching in computational drug design, Drug Discov Today, vol.13, issue.1-2, pp.23-29, 2008. ,
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubuleassociated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase, Biochem J, vol.355, pp.609-615, 2001. ,
FDA-approved small-molecule kinase inhibitors, Trends Pharmacol Sci, vol.36, issue.7, pp.422-439, 2015. ,
Small-molecule kinase inhibitors: an analysis of FDAapproved drugs, Drug Discov Today, vol.21, issue.1, pp.5-10, 2016. ,
Microglial pathology in Down syndrome, Acta Neuropathol, vol.122, issue.4, pp.455-466, 2011. ,
Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors, Science, vol.242, issue.4880, pp.933-935, 1988. ,
Cerebral amyloid angiopathy: emerging concepts, J Stroke, vol.17, issue.1, pp.17-30, 2015. ,
Mechanisms of Amyloid-beta Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease, Biomol Ther (Seoul), vol.20, issue.3, pp.245-255, 2012. ,
Prefrontal cortex and hippocampus subserve different components of working memory in rats, Learn Mem, vol.15, issue.3, pp.97-105, 2008. ,
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model, Neuron, vol.53, issue.3, pp.337-351, 2007. ,
, , 2006.
, Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice, J Biol Chem, vol.281, issue.47, pp.36180-36186
TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function, Neuron, vol.97, issue.5, pp.1023-1031, 1027. ,
2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor, Acta Crystallogr D Biol Crystallogr, vol.49, pp.362-365, 1993. ,
URL : https://hal.archives-ouvertes.fr/hal-00126646
Protein kinase specificity. A strategic collaboration between kinase peptide specificity and substrate recruitment, Cell Cycle, vol.4, issue.1, pp.52-56, 2005. ,
Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M, J Biol Chem, vol.278, issue.49, pp.49573-49581, 2003. ,